Six patients initially had metastatic lesions, 18 of the 137 patients who initially had early endometrial cancer, relapsed (16 and 2 patients with wild-type and mutated AKT1, respectively), and 21 patients died of any cause. The gene discussed is AKT1; the disease is endometrial cancer.